Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

2016 ◽  
Vol 94 (1) ◽  
pp. 2 ◽  
Author(s):  
H. Lukka ◽  
P. Stephanie ◽  
D. Bruner ◽  
J.P. Bahary ◽  
C.A.F. Lawton ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Patient Reported ◽  
Randomized Phase 2

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma

2019 ◽  
Vol 60 (11) ◽  
pp. 2705-2711 ◽  
Author(s):  
Bastian von Tresckow ◽  
Michelle Fanale ◽  
Kirit M. Ardeshna ◽  
Robert Chen ◽  
Julia Meissner ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Classical Hodgkin Lymphoma ◽  
Phase 2 Study ◽  
Patient Reported

Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-Hodgkin lymphoma (iNHL).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19554-e19554 ◽  
Author(s):  
Nina D. Wagner-Johnston ◽  
Ajay K. Gopal ◽  
Brad S. Kahl ◽  
Sven De Vos ◽  
Stephen J. Schuster ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study ◽  
Patient Reported

scholarly journals Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma

2020 ◽  
Vol 126 (1) ◽  
pp. 73-82 ◽  
Author(s):  
Sumanta K. Pal ◽  
David F. McDermott ◽  
Michael B. Atkins ◽  
Bernard Escudier ◽  
Brian I. Rini ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document